NBP
NovaBridge Biosciences
1.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
NovaBridge Biosciences (NBP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -16 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 8.4 | -11 | – | – | 13 | -15 | -16 | -16 | -34 | |
| – | – | – | – | 0.2 | 0.2 | – | – | 1.5 | 0.2 | 2.2 | 2.2 | 6.1 | |
| 67 | 29 | -14 | 8.3 | 2.1 | 0.8 | 2.2 | 2.1 | 10 | 3.9 | 3.4 | 3.4 | 21 | |
| – | – | – | – | 18 | -1.1 | – | – | 50 | 10 | -2.9 | -2.9 | 54 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 1.0 | |
| – | – | – | – | – | – | – | – | -0.4 | – | 6.1 | 6.1 | – | |
| – | – | – | – | 0.0 | 0.0 | – | – | 0.0 | 0.0 | – | – | – | |
| – | – | – | – | 0.0 | 0.0 | – | – | 433 | -3.0 | 0.4 | 0.4 | 431 | |
| -226 | – | – | – | -73 | -11 | – | – | 446 | -17 | -213 | – | – | |
| – | – | – | – | 8.4 | -11 | – | – | 13 | -15 | -17 | -17 | -35 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.